» Articles » PMID: 34830000

The Importance of 6-Aminohexanoic Acid As a Hydrophobic, Flexible Structural Element

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Nov 27
PMID 34830000
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

6-aminohexanoic acid is an ω-amino acid with a hydrophobic, flexible structure. Although the ω-amino acid in question is mainly used clinically as an antifibrinolytic drug, other applications are also interesting and important. This synthetic lysine derivative, without an α-amino group, plays a significant role in chemical synthesis of modified peptides and in the polyamide synthetic fibers (nylon) industry. It is also often used as a linker in various biologically active structures. This review concentrates on the role of 6-aminohexanoic acid in the structure of various molecules.

Citing Articles

Whole Blood Metabolomic Profiling of Mice with Tacrolimus-Induced Chronic Nephrotoxicity: NAD Depletion with Salvage Pathway Impairment.

Nishida S, Ishima T, Iwami D, Nagai R, Aizawa K Antioxidants (Basel). 2025; 14(1).

PMID: 39857396 PMC: 11760425. DOI: 10.3390/antiox14010062.


Peptide PET Imaging: A Review of Recent Developments and a Look at the Future of Radiometal-Labeled Peptides in Medicine.

Shabsigh M, Solomon L Chem Biomed Imaging. 2024; 2(9):615-630.

PMID: 39474267 PMC: 11503725. DOI: 10.1021/cbmi.4c00030.


Biophysical characterization of synthetic adhesins for predicting and tuning engineered living material properties.

Costan S, Ryan P, Kim H, Wolgemuth C, Riedel-Kruse I Matter. 2024; 7(6):2125-2143.

PMID: 39165662 PMC: 11335339. DOI: 10.1016/j.matt.2024.03.019.


Quantitative Hydrogen-Deuterium Exchange Mass Spectrometry for Simultaneous Structural Characterization and Affinity Indexing of Single Target Drug Candidate Libraries.

Wolf E, Herasymenko O, Kutera M, Lento C, Arrowsmith C, Ackloo S Anal Chem. 2024; 96(32):13015-13024.

PMID: 39074309 PMC: 11326436. DOI: 10.1021/acs.analchem.4c01001.


Synthesis, Radiolabeling, and Biodistribution Study of a Novel DOTA-Peptide for Targeting Vascular Endothelial Growth Factor Receptors in the Molecular Imaging of Breast Cancer.

Ebrahimi F, Zargari N, Akhlaghi M, Asghari S, Abdi K, Balalaie S Pharmaceutics. 2024; 16(7).

PMID: 39065596 PMC: 11279866. DOI: 10.3390/pharmaceutics16070899.


References
1.
Midura-Nowaczek K, Bruzgo I, Roszkowska-Jakimiec W, Markowska A . Effects of epsilon-aminocaproiloaminoacids on the amidolytic activity of tissue plasminogen activator, urokinase and kallikrein. Acta Pol Pharm. 2004; 61(1):75-6. View

2.
Al-Horani R, Desai U . Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders. Med Res Rev. 2014; 34(6):1168-216. PMC: 8788159. DOI: 10.1002/med.21315. View

3.
Tirand L, Thomas N, Dodeller M, Dumas D, Frochot C, Maunit B . Metabolic profile of a peptide-conjugated chlorin-type photosensitizer targeting neuropilin-1: an in vivo and in vitro study. Drug Metab Dispos. 2007; 35(5):806-13. DOI: 10.1124/dmd.106.013763. View

4.
CHENG C, Lo V, Chen J, Chen W, Lin C, Lin H . Synthesis and DNA nicking studies of a novel cyclic peptide: cyclo[Lys-Trp-Lys-Ahx-]. Bioorg Med Chem. 2001; 9(6):1493-8. DOI: 10.1016/s0968-0896(01)00043-8. View

5.
Lu J, Chen Z, Yan Y, Knapp S, Schugar H, Chen K . Aminohexanoic hydroxamate is a potent inducer of the differentiation of mouse neuroblastoma cells. Cancer Lett. 2000; 160(1):59-66. DOI: 10.1016/s0304-3835(00)00561-9. View